Published in Breast Cancer Res Treat on July 28, 2010
Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study. J Clin Oncol (2011) 0.93
A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors. PLoS One (2014) 0.92
Synchronous and metachronous breast malignancies: a cross-sectional retrospective study and review of the literature. Biomed Res Int (2014) 0.81
The molecular and clinicopathologic characteristics of bilateral breast cancer. Sci Rep (2013) 0.76
Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype. Int J Clin Exp Pathol (2013) 0.75
Noninvasive Surface Imaging of Breast Cancer in Humans using a Hand-held Optical Imager. Biomed Phys Eng Express (2015) 0.75
Volumetric modulated arc therapy for synchronous bilateral whole breast irradiation - A case study. Rep Pract Oncol Radiother (2015) 0.75
Bilateral Breast Irradiation Using Hybrid Volumetric Modulated Arc Therapy (h-VMAT) Technique: A Planning Case Report. Cureus (2016) 0.75
[Synchronous bilateral breast cancer: experiences in the Mohammed VI Cancer Treatment Center, CHU Ibn Rochd, Casablanca]. Pan Afr Med J (2016) 0.75
Bilateral synchronous carcinoma breast- a rare case presentation. Springerplus (2015) 0.75
Breast-Conserving Surgery in Bilateral Breast Cancer. Ann Surg Oncol (2015) 0.75
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation (2007) 5.05
Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg (2010) 4.59
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract (2011) 3.06
Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med (2004) 3.06
A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Lancet Oncol (2011) 2.95
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res (2009) 2.59
Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol (2008) 2.30
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer (2010) 2.10
Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist (2010) 1.91
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. Chest (2008) 1.80
Sentinel lymph node biopsy. BMJ (2004) 1.76
MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol (2010) 1.72
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat (2011) 1.70
MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res (2008) 1.69
Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD (2011) 1.66
A review of expression profiling of circulating microRNAs in men with prostate cancer. BJU Int (2012) 1.60
Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry (2010) 1.60
Can a teaching intervention reduce interobserver variability in LVEF assessment: a quality control exercise in the echocardiography lab. JACC Cardiovasc Imaging (2011) 1.58
The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer. Breast Cancer Res Treat (2009) 1.55
The effect of decreasing length of stay on discharge destination and readmission after coronary bypass operation. Surgery (2002) 1.52
The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) (2013) 1.46
Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer (2010) 1.46
Oral cavity examination: beyond the core curriculum? Br J Oral Maxillofac Surg (2011) 1.45
MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem (2012) 1.43
MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis (2011) 1.43
Aerosolized intraperitoneal local anesthetic for laparoscopic surgery: a randomized, double-blinded, placebo-controlled trial. World J Surg (2015) 1.42
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39
Incremental exercise test design and analysis: implications for performance diagnostics in endurance athletes. Sports Med (2007) 1.30
Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer. BMC Mol Biol (2007) 1.29
Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Res Ther (2010) 1.29
11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26
The effect of breast cancer awareness month on internet search activity--a comparison with awareness campaigns for lung and prostate cancer. BMC Cancer (2011) 1.26
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.23
Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. Br J Gen Pract (2008) 1.23
Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol Cancer Res (2010) 1.23
Circulating miRNA signatures: promising prognostic tools for cancer. J Clin Oncol (2010) 1.20
Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int J Cancer (2009) 1.17
miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy. Int J Colorectal Dis (2012) 1.16
Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer (2011) 1.16
Representation of cancer in the medical literature--a bibliometric analysis. PLoS One (2010) 1.15
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
Breast cancer research output, 1945-2008: a bibliometric and density-equalizing analysis. Breast Cancer Res (2010) 1.12
Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer. Ann Surg (2009) 1.09
Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer. BMC Mol Biol (2010) 1.06
SMART MOVE - a smartphone-based intervention to promote physical activity in primary care: study protocol for a randomized controlled trial. Trials (2013) 1.04
Low penetrance breast cancer predisposition SNPs are site specific. Breast Cancer Res Treat (2008) 1.03
The therapeutic potential of microRNAs: disease modulators and drug targets. Pharm Res (2011) 1.01
Malignant phyllodes tumour with liposarcomatous differentiation, invasive tubular carcinoma, and ductal and lobular carcinoma in situ: case report and review of the literature. Patholog Res Int (2010) 1.00
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet (2013) 1.00
Circulating microRNAs: promising breast cancer Biomarkers. Breast Cancer Res (2011) 0.99
Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer. Stem Cells (2011) 0.97
The Irish DAFNE study protocol: a cluster randomised trial of group versus individual follow-up after structured education for type 1 diabetes. Trials (2009) 0.97
Relationship between circulating and tissue microRNAs in a murine model of breast cancer. PLoS One (2012) 0.96
The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer. PLoS One (2012) 0.95
Digital rectal examination: national survey of undergraduate medical training in Ireland. Postgrad Med J (2007) 0.95
Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications. Int J Cancer (2012) 0.94
The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. PLoS One (2011) 0.94
Lactobacillus helveticus glycosyltransferases: from genes to carbohydrate synthesis. Glycobiology (2002) 0.93
Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study. Nephrol Dial Transplant (2007) 0.93
Smart phone apps: smart patients, steer clear. Patient Educ Couns (2012) 0.93